02.02.2024 - By Dr. John Fralick and Dr. Michael Fralick
Welcome back Rounds Table Listeners! In this throwback episode, Drs. John and Mike Fralick discuss two papers – one, exploring the use of SGLT2 inhibitors in CKD, and the second investigating the effect of RAS inhibitor discontinuation on the progression of CKD. Empagliflozin in Patients with Chronic Kidney Disease (0:00 – 9:00). Renin-Angiotensin System Inhibition in ...
The post TBT – Chronic Kidney Disease appeared first on Healthy Debate.